[HTML][HTML] Leveraging big data of immune checkpoint blockade response identifies novel potential targets
Background The development of immune checkpoint blockade (ICB) has changed the way
we treat various cancers. While ICB produces durable survival benefits in a number of …
we treat various cancers. While ICB produces durable survival benefits in a number of …
Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular …
Atezolizumab (TECENTRIQ®) and nivolumab (OPDIVO®) are both immunotherapeutic
indications targeting programmed cell death 1 ligand 1 (PD-L1) and programmed cell death …
indications targeting programmed cell death 1 ligand 1 (PD-L1) and programmed cell death …
Low expression of PGC-1β and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive …
KM Laurin, K Coutu-Beaudry, A Salazar, N Meribout… - Cancer Letters, 2022 - Elsevier
Mitochondria are specialized metabolic and immune organelles that have important roles in
tumor progression, metastasis, and response to chemotherapy and immunotherapy …
tumor progression, metastasis, and response to chemotherapy and immunotherapy …